Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 193

1.

The application of toxicokinetic data to dosage selection in toxicology studies.

Morgan DG, Kelvin AS, Kinter LB, Fish CJ, Kerns WD, Rhodes G.

Toxicol Pathol. 1994 Mar-Apr;22(2):112-23.

2.

Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.

EFSA GMO Panel Working Group on Animal Feeding Trials.

Food Chem Toxicol. 2008 Mar;46 Suppl 1:S2-70. doi: 10.1016/j.fct.2008.02.008. Epub 2008 Feb 13. Review.

PMID:
18328408
3.
4.

Environmental risk assessment of pharmaceutical drug substances--conceptual considerations.

Länge R, Dietrich D.

Toxicol Lett. 2002 May 10;131(1-2):97-104. Review.

PMID:
11988362
5.
6.

The use of toxicokinetic and toxicodynamic data in risk assessment: an international perspective.

Gundert-Remy U, Sonich-Mullin C; IPCS Uncertainty and Variability Planning Workgroup and Drafting Group (International Program on Chemical Safety's).

Sci Total Environ. 2002 Apr 8;288(1-2):3-11.

PMID:
12013545
7.

Low-level chemical sensitivity: a perspective from behavioral toxicology.

Weiss B.

Toxicol Ind Health. 1994 Jul-Oct;10(4-5):605-17.

PMID:
7778118
8.

Toxicokinetics in the National Toxicology Program.

Goehl TJ.

NIDA Res Monogr. 1997;173:273-304. Review.

PMID:
9260193
9.

Purpose and guidelines for toxicokinetic studies within the National Toxicology Program.

Buchanan JR, Burka LT, Melnick RL.

Environ Health Perspect. 1997 May;105(5):468-71. Review.

10.

Future of toxicology--low-dose toxicology and risk--benefit analysis.

Rietjens IM, Alink GM.

Chem Res Toxicol. 2006 Aug;19(8):977-81.

PMID:
16918235
11.

Integration of safety pharmacology endpoints into toxicology studies.

Luft J, Bode G.

Fundam Clin Pharmacol. 2002 Apr;16(2):91-103.

PMID:
12031062
12.

Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity.

Müller L, Gocke E, Lavé T, Pfister T.

Toxicol Lett. 2009 Nov 12;190(3):317-29. doi: 10.1016/j.toxlet.2009.04.003. Epub 2009 Apr 10.

PMID:
19443141
13.

Precision of estimates of an ADI (or TDI or PTWI).

Speijers GJ.

Regul Toxicol Pharmacol. 1999 Oct;30(2 Pt 2):S87-93. Review.

PMID:
10597619
14.

The use of in vitro data in risk assessment.

Bernauer U, Oberemm A, Madle S, Gundert-Remy U.

Basic Clin Pharmacol Toxicol. 2005 Mar;96(3):176-81. Review.

15.

Evidence-based toxicology: a comprehensive framework for causation.

Guzelian PS, Victoroff MS, Halmes NC, James RC, Guzelian CP.

Hum Exp Toxicol. 2005 Apr;24(4):161-201. Review.

PMID:
15957536
16.

Toxicology and genetic toxicology in the new era of "toxicogenomics": impact of "-omics" technologies.

Aardema MJ, MacGregor JT.

Mutat Res. 2002 Jan 29;499(1):13-25. Review.

PMID:
11804602
17.

Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.

Thybaud V, Aardema M, Clements J, Dearfield K, Galloway S, Hayashi M, Jacobson-Kram D, Kirkland D, MacGregor JT, Marzin D, Ohyama W, Schuler M, Suzuki H, Zeiger E; Expert Working Group on Hazard Identification and Risk Assessment in Relation to In Vitro Testing.

Mutat Res. 2007 Feb 3;627(1):41-58. Epub 2006 Nov 27.

PMID:
17126066
18.
19.

Probabilistic framework for the estimation of the adult and child toxicokinetic intraspecies uncertainty factors.

Pelekis M, Nicolich MJ, Gauthier JS.

Risk Anal. 2003 Dec;23(6):1239-55.

PMID:
14641898
20.

Concomitant toxicokinetics: techniques for and interpretation of exposure data obtained during the conduct of toxicology studies.

Dahlem AM, Allerheiligen SR, Vodicnik MJ.

Toxicol Pathol. 1995 Mar-Apr;23(2):170-8. Review.

Items per page

Supplemental Content

Write to the Help Desk